4,11 Similar to erythromycin, they are less effective in the treatment of Lyme

disease. The combination of a macrolide with lysosomotropic agents, especially

hydroxychloroquine, anecdotally has been suggested to be associated with increased

symptom relief probably related to combined anti-inflammatory activity rather than

direct antimicrobial activity.

3 Doxycycline is well absorbed orally and is less

expensive than parenteral ceftriaxone or cefotaxime. Doxycycline has a long serum

half-life of 18 to 22 hours. In addition, doxycycline penetrates into the cerebrospinal

fluid (CSF) at concentrations of at least 10% of serum levels, even in the absence of

meningeal inflammation. Although not as significant as with tetracycline, doxycycline

can complex with divalent or trivalent cations in the gut, with an associated decrease

in oral absorption. On the other hand, administering doxycycline with food, to

minimize nausea, is recommended.

3 Compared with other tetracyclines, doxycycline

has the least affinity for divalent calcium cations, and oral absorption is reduced by

only 20% if given with milk. The major side effect of doxycycline is phototoxicity,

which is of concern because Lyme disease usually occurs during sunny times of the

year. A less recognized side effect is the risk of doxycycline-induced esophageal

ulceration. Patients should be instructed to never take doxycycline or other

tetracyclines near bedtime and to take the medication while standing up with at least

240 mL of clear fluid, especially with the capsule formulation. Despite less in vitro

activity compared with some β-lactam antibiotics, B. burgdorferi is sufficiently

susceptible to doxycycline, and clinical experience with doxycycline has been very

favorable. In conclusion, doxycycline was a suitable choice for M.K.

Chronic Lyme Arthritis

CASE 82-2, QUESTION 4: M.K. continues to have knee inflammation for 3 months after receiving a second

course of antibiotic treatment and is now considered to have Lyme arthritis. Should antibiotic therapy be

repeated for M.K.’s arthritis?

Acute Lyme arthritis occurs from the accumulation of neutrophils, cytokines,

immune complexes, complement, and mononuclear cells induced by the spirochete.

12

Appropriate antimicrobial treatment of acute Lyme arthritis is usually successful, and

doxycycline, amoxicillin, or cefuroxime axetil is recommended for adult patients,

such as M.K., if there is no clinical evidence of neurologic disease.

11 Treatment for

Lyme arthritis typically requires 28 days of therapy.

11 A minority subset of patients

may have persistent Lyme arthritis.

12

It is very unlikely that this is attributable to the

continued presence of B. burgdorferi in the joint, but rather to the patient’s continued

inflammatory response or autoimmunity.

12 Polymerase chain reaction (PCR) testing of

synovial fluid can be considered, and if negative, symptomatic therapies may be

offered rather than repeated antibiotic courses. Such patients often respond well to

synovectomy, suggesting that the presence of synovitis may not be the result of

persistence of the infection. Nonsteroidal anti-inflammatory agents, diseasemodifying antirheumatic agents, intra-articular corticosteroid injections, or

synovectomy may be offered.

3,11 However, it should be noted that before the

antibiotic treatment era for Lyme disease, even the most prolonged cases of persistent

Lyme arthritis eventually improved without treatment, although sometimes lasting for

months to years.

12

Neurologic Lyme Disease

CASE 82-3

QUESTION 1: E.T., a 57-year-old female, presents to her PCP with symptoms of early neurologic Lyme

disease, including mild memory and cognitive deficits. Serum two-tier IgG seropositivity was confirmed. Should

E.T. be treated with antibiotics? If so, how long should she be treated?

Although rare, late neurologic complications of Lyme disease may present as

encephalopathy, peripheral neuropathy, or encephalomyelitis.

4,11 Although the Lyme

Borrelia species found in Europe do not strictly overlap with those species found in

the United States, there are no data to support a differential response to antibiotic.

10

Based on these studies, oral doxycycline can be considered as first-line therapy for

neurologic Lyme disease in Europe and for ambulatory patients with early neurologic

Lyme disease in the United States. An oral antibiotic treatment regimen may suffice in

cases of early neurologic disease, but parenteral regimens are appropriate for severe

cases.

13

In conclusion, E.T. can be treated with doxycycline administered orally and

should be reassessed following treatment.

p. 1720

p. 1721

Post-Lyme Disease Syndromes

CASE 82-4

QUESTION 1: A friend who has been treated with a 4-week course of antibiotics for Lyme disease calls you

to say that she has lingering symptoms and she thinks it’s “chronic Lyme disease.” She’d like more information

about it. How should you respond?

Chronic Lyme disease is a confusing term, and most authorities agree that there

may be “Post-Treatment Lyme Disease Syndrome,” (PTLDS).

4 Although the exact

cause is unknown, most medical experts believe that the lingering symptoms that can

occur are the result of residual damage to tissues and the immune system. Clinical

findings in patients may include fatigue, widespread musculoskeletal pain, cognitive

difficulties, or subjective symptoms of such severity that a substantial reduction in

quality of life has occurred. The subjective symptoms must include an onset within 6

months of the initial Lyme disease diagnosis and persistence for at least 6 months

after completion of antimicrobial therapy. If adherence to a recommended Lyme

treatment regimen is confirmed, the existence of symptomatic, chronic infection by B.

burgdorferi is difficult to confirm. After appropriately targeted antibiotic therapy for

early Lyme disease, treatment failure is exceedingly rare. The organism has not been

shown to develop antibiotic resistance.

3 For these patients with chronic subjective

symptoms for more than 6 months, repeated or prolonged antibiotic therapy is not

useful or recommended.

4,11

The friend should be encouraged to seek additional diagnostic workup for other

diseases. Even in patients who have had verified Lyme disease, the aches and pains

of daily living they experience appear to be more related to their post-treatment

symptoms than to Lyme disease itself.

4

Lyme Disease Prevention

CASE 82-5

QUESTION 1: A family living in a Lyme disease endemic area is concerned regarding their risk for

contracting the disease. How would you advise them on Lyme disease prevention and overall protection from

tick-borne disease?

Although some vector-borne diseases are prevented through vector control, this

has proven difficult for tick-borne diseases because of a lack of efficacy or

environmental concerns with the use of pesticides. Evaluated methods include habitat

destruction by fire, chemical spraying agents such as acaricides to achieve tick

eradication, culling or removal of host deer, or protection of mice from tick

infestation.

13

Currently, there are limited vaccines available for tick-borne and mosquito-borne

illnesses.

14 A Lyme disease vaccine for humans is no longer available in the United

States. Citing low demand, the U.S. manufacturer discontinued production in 2002.

Clinical trials are currently underway for candidate Lyme borreliosis vaccines.

15

The first step in prevention of Lyme disease is personal protection and tick

avoidance.

16,17 Tick repellents may be applied to the skin or clothing. One basic

chemical category of insect repellant is the synthetic agents, such as N,N-diethyl-μtoluamide (DEET), picaridin (also known as icaridin in Europe), and insect repellent

(IR) 3535 (ethyl butylacetylaminopropionate). The second chemical category of

repellant is the plant-derived oils and synthetics, such as oil of lemon eucalyptus or

PMD (para-menthane-3,8-diol), which is an extract of the leaves of lemon

eucalyptus, Corymbia citriodora, a synthesized version of oil of lemon eucalyptus.

The use of DEET skin repellent has evolved as the standard repellant for mosquito

and tick-borne diseases. In combination with a permethrin clothing, DEET appears to

offer adequate protection. DEET has been tested against Ixodid ticks for repellence

and is more effective than dibutyl phthalate, dimethyl phthalate, pyrethrum, and two

combination products.

16,17 DEET is generally safe; however, excessive DEET

application has been associated with seizures in children.

17,18 These are rare events,

however, and if the products are used according to their labeling, the adverse

reaction risk is low, even for children older than 2 months of age.

3 Prolonged or

excessive application is not recommended. It may be prudent to use the lowest

effective concentration of DEET-containing repellents, such as those containing 20%

to 30%. To minimize DEET toxicity, the product should be applied sparingly,

inhalation or introduction into the eyes should be avoided, repellent-treated skin

should be washed when coming inside, use on children’s hands (that are likely to

have contact with the eyes or mouth) should be avoided, and it should be applied

only to intact skin or clothing.

Picaridin was developed in Europe in the 1990s and released in the United States

about 10 years ago. A couple of advantages over DEET include the lack of a

chemical odor and its nonsticky or greasy feel. It is also safe to use on plastics,

whereas DEET may damage certain synthetics including eyeglass frames. IR3535,

originally marketed in the United States as a skin emollient and moisturizer, was then

adopted for use as an insect repellant. Plant-derived IRs, such as oil of lemon

eucalyptus or PMD, have demonstrated efficacy against the tick vectors of Lyme

disease (Ixodes scapularis, Ixodes pacificus) and Rocky Mountain spotted fever

(Dermacentor andersoni).

1

A literature review between 2000 and 2012 on the efficacy of repellants against

various mosquito and tick species noted that there are only limited studies conducted

on tick behavior and repellant efficacy against the tick species Ixodes.

18,19 The use of

picaridin, IR 3535, and PMD were also reviewed as part of this study. Results of this

study found that the use of IR 3535 provided the longest protection against Ixodes

scapularis, whereas DEET and commercial products containing picaridin or PMD

demonstrated a better response than IR 3535 against Ixodes ricinus.

18

In situations in

which environmental exposure to disease-transmitting ticks, biting midges, sandflies,

or blackflies is anticipated, topical repellants containing IR 3535, picaridin, or oil of

eucalyptus (or PMD) would offer better protection than topical DEET alone.

1

(Refer

to Chapter 81, Parasitic Infections, Table 81-2, Mosquito Protection Measures for

additional information on insect repellants).

Physical barriers to ticks, such as wearing protective garments—long pants, and

long-sleeved shirts—tucking shirts into pants and pants into boots, and wearing

closed-toed shoes, prevent infection.

1 Ticks are easier to spot on light-colored

clothing. Checking the body for ticks regularly is recommended; any that are found

should be promptly removed. Avoiding tick habitats is the best protection against

tick-borne diseases. Effective postexposure antibiotic prophylaxis can be

administered in Lyme disease endemic areas after a tick bite.

RELAPSING FEVER

Relapsing fever, a bacterial infection caused by a variety of Borrelia species, causes

episodes of fever, nausea, headache, and muscle and joint aches. Of the two types of

relapsing fever, tick-borne relapsing fever (TBRF) occurs in the western US and

louse-borne relapsing fever (LBRF) is generally restricted to refugee settings in

developing parts of the world.

5

Tick Vector

The predominant tick vector for relapsing fever is of the genus Ornithodoros, a softbodied tick. These ticks feed on wild rodents

p. 1721

p. 1722

or domestic animals and, incidentally, on humans. In North America, three tick

species carry the agents of endemic relapsing fever with apparent strict specificity. In

fact, the names of the responsible Borrelia species have been adopted from the three

tick species that transmit them: Ornithodoros hermsii, Ornithodoros parkeri, and

Ornithodoros turicata.

20 Although the ticks themselves may serve as reservoir hosts,

the Borrelia usually circulate among wild rodents, ticks, and possibly birds.

5 Similar

to Lyme disease, greater worldwide variations of endemic cycles and vectors for

TBRF may exist than in North America.

TICK GEOGRAPHY

In North America, relapsing fever is an uncommon disease largely confined to the

geographic distribution of the tick species that harbor the Borrelia. In the United

States, most cases of TBRF have occurred in 14 western states and are caused by B.

hermsii.

5 These ticks are usually found in the remote natural settings of the mountains

and semiarid plains of the far west and Mexico. TBRF can develop when people

visit tick- or rodent-infested cabins or summer homes. While TBRF is spread by

multiple tick species, Ornithodoros hermsii is the tick responsible for most cases in

the United States usually at altitudes of 1,500 to 8,000 feet. The health significance of

O. parkeri and O. turicata transmits its Borrelia at lower altitudes in the Southwest,

where they inhabit caves and the borrows of ground squirrels, prairie dogs, and

burrowing owls.

SPIROCHETAL BEHAVIOR

Ticks acquire spirochetes from blood feeding on small wild rodents. If high levels of

Borrelia are present in the animal’s blood, large numbers of spirochetes will be

ingested by the tick and reside in the tick’s midgut. During the next few days, the

spirochetes invade the midgut wall, traverse the hemolymph system, and within a few

weeks infect the salivary glands as well as other tick tissues and organs. Females

may develop infected ovaries and transmit Borrelia to offspring in some

Ornithodoros species, but this is rare in O. hermsii.

20 Having reached the tick’s

salivary glands, the spirochetes are poised to invade the tick’s next host.

TICK BEHAVIOR

In contrast to the hard-bodied ticks, these soft ticks feed rapidly, often detaching after

30 to 90 minutes.

20,21 They feed at night while people are sleeping, and their bite is

usually painless. Therefore, most people are unaware that they have been bitten.

18

Disease Characterization

The hallmark of endemic relapsing fever is an abrupt onset of high fever (often

>39°C) after an incubation period of 4 to 18 days.

20 The patient may experience

shaking chills, severe headache, abdominal pain, myalgias, arthralgias, nausea,

vomiting, and malaise. A few cases of acute respiratory distress syndrome have

recently been recognized.

20 The fever usually breaks in 3 days (range, 12 hours to 17

days) in untreated patients.

20 After a variable afebrile period of 3 to 36 days (usually

7 days), cyclic periods of fever and constitutional symptoms reappear. Each febrile

attack progressively diminishes in severity. Three to five relapses typically occur in

untreated patients.

Routine laboratory testing is of little value. Moderate anemia and an increased

erythrocyte sedimentation rate (ESR) are common. Leukocyte counts may be normal,

yet moderate-to-severe thrombocytopenia is commonly observed but is considered

nonspecific. The diagnosis of relapsing fever is made by direct observation of the

spirochete on a peripheral blood smear while the patient is febrile.

20 Observation of

the smear is enhanced with Wright or Giemsa staining. Few diagnostic laboratories

perform antibody serology tests; however, these tests lack specificity.

20 Skin biopsy

of a rash to identify the spirochete is unreliable. Direct culture of the spirochete from

the blood into a special culture medium is the most specific diagnostic tool, but this

is a slow technique confined to research laboratories.

TREATMENT

These Borrelia have not demonstrated antibiotic resistance. Successful treatment

regimens usually include a 7- to 10-day course of antibiotics.

5,20 Tetracycline (500

mg every 6 hours for 10 days) is the preferred regimen. Erythromycin is an effective

alternative at a dose of 500 mg (or 12.5 mg/kg) every 6 hours for 10 days. For

individuals experiencing central nervous system (CNS) involvement, ceftriaxone (2

g/day for 10–14 days) is preferred. Hospitalization and administration of IV

antibiotics may be required in severely ill patients.

CASE 82-6

QUESTION 1: T.J. is a 49-year-old man who visits his PCP with a sudden onset of high fever, severe

headache, malaise, nausea, vomiting, and myalgias. He returned a week ago, at the end of August, from a stay

in a rustic cabin on the north rim of the Grand Canyon. His PCP orders a manual complete blood count (CBC)

and chemistry panel and asks the laboratory to observe a blood smear with Giemsa staining. T.J.’s recent visit

and outdoor activities are consistent with areas with prior outbreaks where relapsing fever has been

documented. After confirming the presence of Borrelia in the blood smear, the PCP prescribes a 10-day course

of tetracycline. Two hours after the first dose, T.J.’s wife calls the physician’s office with concerns that the

disease is worsening. T.J. experiences an increased temperature, faintness, and chills, and has a rapid pulse and

respiration rate. What do these symptoms represent? Is this an adverse drug reaction?

Up to 54% of patients with relapsing fever experience a reaction, a Jarisch–

Herxheimer reaction, to the first dose of antibiotic (see Chapter 72 Sexually

Transmitted Diseases).

21

It may occur in LBRF, TBRF, and in other spirochetal

diseases such as syphilis or Lyme disease.

3 The dramatic reaction consists of a rise

in temperature, chills, myalgias, tachycardia, hypotension, increased respiratory rate,

and vasodilation.

20 Treatment of the reaction consists of supportive care. Severe

reactions may require hospitalization for vital sign monitoring and management of

hypovolemia. Although this is a reaction to the administration of an antibiotic drug, it

is not an allergic response, and the antibiotic should be continued.

BORRELIA MIYAMOTOI

CASE 82-6, QUESTION 2: T.J. continues with antibiotic therapy and his symptom resolves. Given his

clinical presentation and findings, his diagnosis and treatment were appropriate. How does Borrelia miyamotoi

typically present and what treatment options are available?

Borrelia miyamotoi is a bacterial species that is closely related to the bacteria that

cause TBRF and distantly related to Borrelia burgdorferi that causes Lyme disease.

While first identified in 1995 in ticks from Japan, B. miyamotoi has been detected in

two species of North American ticks, the black-legged or deer tick (I. scapularis) and

the western black-legged tick (I. pacificus). The first human cases of infection were

identified in Russia and described in 2011, followed by the first recognized cases in

northeastern United States in 2013.

22 To date, there are less than 60 well-documented

cases of B. miyamotoi in the United States. Because ticks are also known to transmit

several diseases, including Lyme disease, anaplasmosis, and babesiosis, researchers

and healthcare providers need to learn more about the transmission and signs and

symptoms of this infection.

p. 1722

p. 1723

Patients with B. miyamotoi infection generally experience nonspecific symptoms

such as fever, chills, headache, myalgia, and arthralgia.

22,23 Unlike Lyme diseases,

rash was an uncommon finding, with only 4 out of 51 patients experiencing a rash.

The blood tests that are used for Lyme disease are not helpful in the diagnosis of B.

miyamotoi infections. Currently, the PCR tests that detect DNA from the organism or

antibody-based tests are used for confirmatory diagnosis. Patients with B. miyamotoi

have been successfully treated with a 2 to 4 week of doxycycline, and amoxicillin

and ceftriaxone have also been used. Borrelia miyamotoi disease will continue to be

evaluated, and it may be an emerging tick-borne infection in the northeastern region

of the United States.

SOUTHERN TICK-ASSOCIATED RASH ILLNESS (STARI)

CASE 82-7

QUESTION 1: G.T., a 47-year-old man living in southern Missouri, recently experienced a rash resembling

EM after a lone star tick bite. Because this tick is not a vector for Lyme disease, what could be the cause and

how should he be managed?

Amblyomma americanum (the lone star tick) is found throughout the southeast and

south-central US and along the Atlantic coast as far north as Maine, and its territory

is expanding.

4 The lone star tick aggressively bites humans in the southern states, as

opposed to I. scapularis ticks.

5,24 Spirochetes detected by microscopy and culture

have been found in 1% to 5% of lone star ticks and are named Borrelia lonestari.

2,5,24

B. lonestari and B. burgdorferi, however, were ruled out as the cause of EM -like

skin lesions known as STARI in one Missouri investigation.

5,24 Attempts to culture

the agent of this Lyme-like illness, although exhaustive, have been unsuccessful.

24 The

causative agent of STARI has not yet been confirmed. There are differences in the

appearance and content of the rashes of STARI and the EM of Lyme disease. For

example, Lyme EM rashes show an abundance of plasma cells contrasted with a

predominantly lymphocytic infiltrate seen in STARI.

24

G.T.’s diagnosis was based on symptoms, geographic location, and tick bite

information. Because the cause of STARI is unknown, no diagnostic tests are

available, nor is it known if antibiotic treatment is necessary or beneficial for

patients. However, because STARI resembles Lyme disease, limited data support

treating STARI with regimens similar to those used for Lyme disease.

24 For example,

doxycycline may be given for 10 to 30 days, with longer durations reserved for

evidence of dissemination beyond the rash, such as fever, severe headache,

lymphadenopathy, or multiple rashes.

25

OTHER BACTERIAL DISEASES: TULAREMIA

Tularemia

ETIOLOGY AND EPIDEMIOLOGY

In 1911, George W. McCoy and Charles W. Chapin from the US Public Health

Service investigated a plague-like disease in wild ground squirrels harvested in

Tulare County, California, and discovered the infectious etiology of tularemia.

25 The

bacterium is a small, pleomorphic, catalase-positive, nonmotile, aerobic,

nonencapsulated, gram-negative coccobacillus now named Francisella tularensis in

honor of Edward Francis for his fieldwork and contributions to tularemia research.

He proposed the terminology tularemia because the disease is associated with

bacteremia.

25

Although tularemia is found worldwide, it occurs primarily in the Northern

Hemisphere.

22 The important reservoir hosts for F. tularensis are wild rabbits, ticks,

and deer flies.

25 The North American tick vectors are Dermacentor variabilis (dog

tick), Amblyomma americanum (lone star tick), and Dermacentor andersoni (wood

tick). Tick-borne tularemia occurs most often in the spring and summer, matching the

likelihood of exposure.

4 Before 1950, most human cases of the disease developed

from direct contact with infected animals, usually hares or rabbits, and tularemia

cases that occurred in the fall or winter were usually associated with hunting season

exposure. Tick bite transmission, however, now accounts for more than half of

tularemia cases west of the Mississippi River in the United States. In summer months,

tick or fly bites appear to be the main mode of transmission of tularemia to humans.

Other animals, such as domestic cats, are susceptible to tularemia and are known to

have transmitted tularemia to humans.

4 Tularemia outbreaks have also occurred

among hamsters purchased from pet shops. Individuals should be careful when

handling any sick or dead animal. Other modes of transmission include ingestion of,

or contact with, infected meat, water, or soil; inhalation of aerosolized bacteria; or

bites from infected animals, mosquitoes, or deerflies.

25 Direct person-to-person

transmission has not been reported.

CLINICAL PRESENTATION

The clinical manifestations of tularemia are related to the mode of transmission,

patient characteristics, and bacterial subspecies causing infection.

25 Classically, six

types of tularemia presentation have been identified: ulceroglandular, glandular,

typhoidal, oculoglandular, oropharyngeal, and pneumonic. The last three forms were

presumably not tick-borne, reflecting alternative avenues of transmission. Today, the

clinical manifestations fall into two main groups: ulceroglandular and typhoidal.

25

Ulceroglandular is the most common form of tularemia, accounting for

approximately 75% of cases.

25 Sixty percent of ulceroglandular cases are

characterized by an ulcer that forms at the site of entry, usually on the lower

extremities, perineum, buttocks, or trunk from arthropods that tend to bite the lower

extremities or on the upper extremities from mammalian bites.

22 The lesion starts as a

firm, erythematous papule that ulcerates and heals over the course of several weeks.

It is accompanied by regional, painful lymphadenopathy, usually inguinal or femoral.

Typhoidal tularemia, occurring in approximately 25% of cases, is characterized by

fever, chills, headache, debilitation, abdominal pain, and prostration. Fever and

chills are common with all forms of tularemia.

25

After exposure to the bacteria and an incubation period of 4 to 5 days, patients

become ill with a sudden onset of fever, chills, headache, cough, arthralgias,

myalgias, fatigue, and malaise. The severity of symptoms is quite variable, ranging

from a mild, limited disease (probably type B tularemia) to rare cases of septic

shock (probably type A tularemia). A hallmark manifestation is a high fever without

an accompanying increase in pulse, or pulse–temperature disparity.

22 Common

complications are mild hepatitis, secondary pneumonia, and pharyngitis. With

antibiotic treatment of uncomplicated tularemia, mortality rates are only 1% to 3%.

Increased morbidity and mortality are seen in the more rare typhoidal forms.

25 The

most lethal form of tularemia is from pulmonary infection.

25

In the healthcare setting,

standard precautions are all that is required when caring for tularemia-infected

patients because they are not a source for secondary infection. However, any

suspected outbreaks should be reported and investigated.

25

DIAGNOSIS

Tularemia can be difficult to diagnose as routine laboratory testing is of little help in

establishing a diagnosis and is limited to the demonstration of an antibody response

to the bacteria. Because an antibody response to the illness requires 10 to 14

p. 1723

p. 1724

days for detection, treatment is usually empiric. The diagnosis is based on clinical

suspicion from the epidemiologic history and the presence of compatible findings.

The customary serologic test demonstrates F. tularensis antibody agglutination.

Although a single-tube agglutination test with a titer of 1:160 or more (or 1:128 or

more using a microagglutination study) in a suspected case is highly suggestive of a

tularemia diagnosis, a fourfold or greater rise in titers between the acute and

convalescent stages 2 weeks apart is diagnostic.

26 After a bout of tularemia,

detectable antibodies may persist for many years.

25

TREATMENT

Antibiotic treatment options for tularemia have included streptomycin, gentamicin,

doxycycline, and ciprofloxacin. Streptomycin was historically the drug of choice for

tularemia, but it is often unavailable commercially. Some clinicians believe that

gentamicin is the best alternative aminoglycoside for the treatment of nonmeningitic

tularemia. Its advantages compared with streptomycin include lower minimal

inhibitory concentrations (MICs), less vestibular toxicity, and wider commercial

availability. Although considered comparable in efficacy to streptomycin, gentamicin

has been associated with increased treatment failure and relapse. Tobramycin is

inferior to gentamicin or streptomycin and should not be used.

In many of the reported studies of antimicrobial therapy for tularemia, short

courses of treatment were used. To prevent tularemia from worsening or relapsing,

longer regimens (10–14 days) should be used, especially in more severe cases.

Jarisch–Herxheimer reactions can occur with antibiotic treatment of tularemia.

Antibiotic prophylaxis for people exposed to those with tularemia is not

recommended, but prophylactic antibiotics might be used for suspected bioterrorism

attacks of tularemia. Acute febrile illness with pneumonia and other signs of infection

occur 3 to 5 days after exposure to airborne tularemia organisms from an

intentionally set weapon. No tularemia vaccines are available in the United States. A

partially protective one was developed in the former Soviet Union but was only used

for at-risk personnel such as for certain laboratory workers.

23 Personal protective

measures, as discussed for Lyme disease, should be used when spending time

outdoors in endemic areas.

25

THE RICKETTSIA: ROCKY MOUNTAIN SPOTTED

FEVER, RICKETTSIA PARKERI INFECTION,

EHRLICHIOSIS, AND ANAPLASMOSIS

Rocky Mountain Spotted Fever (RMSF)

Rocky Mountain spotted fever is the most prevalent and virulent rickettsial disease in

the United States. As early as 1872, RMSF infected white settlers of the Northwest

and it may have been prevalent in Native Americans of the region before that time. It

was first described in residents of the Bitterroot, Snake, and Boise river valleys of

Montana and Idaho in the late 1800s. Howard Ricketts discovered the causative

agent, Rickettsia rickettsii, in 1908.

26 The rickettsia is a small (0.3 × 1 μm),

pleomorphic, weakly gram-negative, obligate intracellular coccobacillus that can

survive only briefly outside of a host.

26

EPIDEMIOLOGY

RMSF is found throughout North America, including the United States, Canada, and

Mexico, and in parts of Central and South America.

26

It has not been documented

outside of the Western Hemisphere. The term “Rocky Mountain spotted fever” is

actually a misnomer because the disease has shifted eastward from the Rocky

Mountain states, and the greatest incidence of RMSF now occurs in North and South

Carolina, Virginia, Oklahoma, Arkansas, and Tennessee.

26,27 Most RMSF infections

arise from tick exposure in rural or suburban locations, although rare outbreaks in

urban environments have occurred.

The prevalence of RMSF is highest in children with 5 to 9 years of age.

28 Another

peak prevalence is seen in men older than 60 years. Risk factors include male sex,

residence in wooded areas, and exposure to tick-infected dogs. RMSF, like other

tick-borne diseases, is highly seasonal, with greatest incidence in late spring and

early summer.

26

TICK VECTORS AND HOSTS

In the east, south, and west coasts of the United States, the tick vector for RMSF has

been identified as the dog tick, Dermacentor variabilis.

2

In the Rocky Mountain

states, the wood tick, D. andersoni, is the vector.

24

In Mexico, the tick vectors are

Rhipicephalus sanguineus and Amblyomma cajennense, with the latter also being

responsible in Central and South America.

24 The brown dog tick, R. sanguineus, has

been identified as a new tick vector for RMSF in a defined area of Arizona.

26–28

Dermacentor ticks feed on humans only during their adult stage.

26 Larval

Dermacentor ticks may be infected while feeding on small mammals that have

sufficient rickettsemia for transmission, such as chipmunks, ground squirrels, cotton

rats, snowshoe hares, and meadow voles. Dogs are not considered reservoirs for R.

rickettsii but are susceptible to RMSF and may introduce infected ticks into

households.

26,27 Adult ticks transmit the rickettsia transovarially to their progeny with

high efficiency and establish newly infected tick lines. If the rickettsia burden is large

in the adult tick, however, it may cause tick death, thereby reducing infected tick

lines. Therefore, there must be nontick reservoirs, as mentioned previously, to

develop newly infected tick generational lines; otherwise, RMSF would slowly

disappear. In summary, ticks are both vectors and hosts for R. rickettsii.

26 Humans

are dead-end accidental hosts of R. rickettsii.

26

DISEASE COURSE, SYMPTOMS, AND FATALITIES

Rickettsia rickettsii is usually transmitted to humans from an infected tick bite.

26 The

organism can also gain access to humans through broken skin if an infected tick is

being crushed with bare fingers, and such crushing may generate infectious aerosols

that might be inhaled. Conjunctival contact with infected tick tissues or feces

provides another route for rickettsial entry. Contaminated blood transfusions and

needle stick injuries have also transmitted R. rickettsii.

26

After introduction of the organisms into the body, the rickettsia spread

hematogenously with a predilection for the vascular endothelium, especially in

capillaries and medium-sized blood vessels.

27 During an incubation period of 2 to 14

days, induced phagocytosis allows rickettsial entry into endothelial cells, where they

replicate by binary fission in the cytoplasm and nuclei of infected cells. This induces

a generalized vasculitis leading to activation of clotting factors, capillary leakage,

and microinfarctions in various organs.

26 Exotoxins are not secreted by rickettsia;

however, they do induce oxidative and peroxidative damage to host cell membranes,

resulting in necrosis.

26

In severe infections, hypotension and intravascular

coagulation may coexist and culminate in cell, tissue, or organ destruction.

Dehydration is an early sign of RMSF, followed by increased vascular

permeability, edema, decreased plasma volume, hypoproteinemia, reduced serum

oncotic pressure, and prerenal azotemia. RMSF is a multisystem disease, but a

particular organ may be the

p. 1724

p. 1725

major focus of the disease. If the brain or lungs are severely infected, death can

ensue. An increased severity of illness is associated with edema, particularly in

children, and hypoalbuminemia. Hypotension is present in 17% of patients and

hyponatremia in 56%. Extensive infection of the pulmonary microvascular

endothelium can cause noncardiogenic pulmonary edema.

A common finding in RMSF is myalgia (72%–83%) or muscular tenderness,

which are manifestations of skeletal muscle necrosis. Striking creatinine kinase

elevations have been described. Thrombocytopenia resulting from consumption of

platelets during intravascular coagulation processes occurs in 35% to 52% of

patients. True disseminated intravascular coagulation with attendant

hypofibrinogenemia is exceptional, however, even in severe or fatal cases.

27 Blood

loss or hemolysis in some may cause anemia, which is seen in 30% of patients and

reflects blood vessel damage. Fatalities usually occur 8 to 15 days after illness onset

if no treatment is given or is delayed. Long-term sequelae from severe forms of

RMSF can include partial paralysis of the lower extremities, gangrene of extremities

requiring amputation, deafness or hearing loss, incontinence, and movement or

speech disorders, but these occur in a minority of patients who receive prompt

antibiotic therapy.

26

“Fulminant” RMSF is best defined as a disease with a rapidly fatal course with

death occurring in approximately 5 days. This form of disease is characterized by an

early onset of neurologic signs and late or absent skin rash; it is highly associated

with glucose-6-phosphate dehydrogenase deficiency, advanced age, male sex, and

possibly heavy alcohol use.

26,27

In the pre-antibiotic era, RMSF mortality rates were

as high as 30%, but they have fallen to 5% in antibiotic-treated cases today.

2,27

The classically defined triad of RMSF symptoms at initial presentation is fever,

rash, and headache, but this is found in only up to 5% of cases during the first 3 days

of illness and up to approximately 60% of cases 2 weeks after exposure.

26,28 The

RMSF skin rash typically begins 2 to 4 days after fever onset as pink, 1- to 5-mm

blanchable macules that later become papules.

27

It begins on the ankles, wrists, and

forearms, and soon thereafter involves the palms or soles. It then spreads to the arms,

thighs, and trunk, and typically evolves into a petechial exanthem. The utility of these

findings in the differential diagnosis is limited because rash may be absent, transient,

or late; it may never become petechial, or it may have an unusual distribution.

DIAGNOSIS

As for most tick-borne diseases, confirmatory serologic analysis is not particularly

useful in early diagnosis of disease. The initial diagnosis is made based on clinical

signs and symptoms and medical history. Because RMSF can be a severe or even

fatal illness, antirickettsial treatment should begin immediately to prevent morbidity

and mortality.

26,27 R. rickettsii is difficult to culture. Immunohistologic demonstration

of R. rickettsii in biopsy specimens of rash lesions is the only approach that can yield

diagnostic results in a timely manner, but this approach is applicable only to those

presenting with a skin rash, and these tests are not readily available.

26

The best serologic test for RMSF is the indirect immunofluorescence assay (IFA)

test, but antibodies typically appear only after 10 to 14 days.

26 More striking

laboratory abnormalities of RMSF disease include a normal leukocyte count with a

shift to the left, hyponatremia, thrombocytopenia, elevated serum transaminases or

creatinine kinase, and CSF pleocytosis. These findings are observed late in the

disease course, however, and are not helpful in early disease recognition.

Clinical findings and history are essential to early diagnosis and successful

treatment. Therapy must precede laboratory confirmation of RMSF.

26

In a febrile,

tick-exposed person with a rash, RMSF should be considered. RMSF should be

strongly considered in febrile children, adolescents, or men older than 60 years of

age, especially if they reside in or have traveled to the southern Atlantic or southcentral US from May through September. A delay in treatment for RMSF beyond 5

days of symptom onset increases the mortality rates from 5% to 22%.

TREATMENT

Doxycycline should be initiated immediately as first-line treatment for RMSF in both

adults and children whenever RMSF is suspected. The recommended treatment is

doxycycline 100 mg every 12 hours for children under 45 kg (100 lbs): 2.2 mg/kg

body weight given twice a day. The standard duration of treatment is 7 to 14 days,

including at least 3 days after the temperature has normalized.

4,5 The use of

doxycycline to treat suspected RMSF in children is standard practice by the CDC and

the American Academy of Pediatrics (AAP) Committee on Infectious Diseases as the

use of alternative antibiotics increases the risk of death. Contraindications to

doxycycline use include history of severe hypersensitivity reactions to tetracyclines,

and in some pregnant patients in which the case of RMSF seems mild,

chloramphenicol may be considered as an alternative antibiotic.

26 However, oral

formulations of chloramphenicol are not available in the United States, and there are

severe risks of adverse of effects with this agent, including gray baby syndrome and

aplastic anemia.

26 The erythromycins, penicillins, sulfonamides, aminoglycosides,

and cephalosporins are not effective for RMSF, and sulfa drugs may worsen

infection.

A crucial component in the management of RMSF is appropriate supportive care.

4

Those with severe disease should be hospitalized and managed with hemodynamic,

renal, pulmonary, and fluid support as needed.

4

PREVENTION

In addition to the same guidelines for prevention of Lyme disease, keeping pets free

of ticks can reduce exposure. Ticks must not be crushed in a way that might introduce

rickettsia into cutaneous lesions, mucous membranes, or the conjunctiva. No RMSF

vaccine is available.

26 Antirickettsial antibiotic prophylaxis after a tick bite is not

warranted as there is no evidence that this approach is effective and it may delay the

onset of the disease.

Spotted Fever Group Rickettsia (SFGR)

In addition to Rickettsia rickettsii, the agent of RMSF, many other rickettsial

pathogens have been recognized and grouped broadly as “Spotted Fever group

Rickettsia (SFGR).”

29

In the United States, these pathogens include Rickettsia parkeri

and Rickettsia 364D, and internationally, there is a growing number of tick-borne

SFGR that are pathogenic to humans.

4,30 Doxycycline treatment is effective and is the

antibiotic of choice for tick-borne SFGR infections.

4

Ehrlichiosis and Anaplasmosis

SPECIES IDENTIFICATION, TICK VECTORS, AND DISEASE HOSTS

Though ehrlichiosis and anaplasmosis are transmitted by two different species of

ticks and generally occur in different regions of the United States, patients may have a

similar clinical presentation.

4,5 The term “ehrlichiosis” may be more broadly applied

to different infections, including Ehrlichia chaffeensis and Ehrlichia ewingii, which

are transmitted by the lone star tick generally in the southeastern and south-central

US, from the eastern seaboard extending westward to Texas. A third species,

provisionally called Ehrlichia muris-like (EML), was identified among patients in

the upper Midwest; however, the tick responsible for transmitting

p. 1725

p. 1726

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more